Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA With High Risk T-Cell ALL & Lymphoma

Clinical trial NCT04972942 · RECRUITING

Trial details

NCT number: NCT04972942
Sponsor: New York Medical College
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

T-cell Acute Lymphoblastic Leukemia T-Cell Acute Lymphoblastic Lymphoma

Start date: 2023-05-22
Primary completion: 2027-09-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.